SU‐FF‐T‐309: Laser‐Accelerated Proton Therapy: Target Chamber Design and Shielding Requirements

C. Ma, I. Veltchev, E. Fourkal, J. Li, J. Fan, T. Lin, W. Luo, Sotirios Stathakis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Recent advances in laser technology have facilitated proton (light ion) acceleration using laser‐induced plasmas. In this work, we investigate target chamber designs and their shielding requirements for a laser‐proton therapy system. Method and Materials: This new therapy system employs laser‐accelerated protons. If successfully developed, it may provide a compact and cost‐effective solution to energy‐ and intensity‐modulated proton therapy (EIMPT). Since laser‐accelerated protons have broad energy and angular distributions, which are not suitable for radiotherapy applications directly, we have designed a compact particle selection and beam collimating system for EIMPT beam delivery. The target chamber contains the laser focusing and target assembles and is connected to the proton beam collimation and particle selection device. Monte Carlo simulations using MCNPX and FLUKA have been performed to verify the shielding walls for the experimental setup, which consist of stainless steel, polystyrene and lead. Results: The primary particles resulting from the laser‐target interaction are protons and electrons. Our particle in cell simulation predicted energy spectra with 300 MeV maximum energy for protons and 20 MeV for electrons for a laser intensity of 1021 W/cm2. The maximum number was 1011 and 1012 per pulse for protons and electron, respectively. Our Monte Carlo simulations showed that a combination of 1/4″ 304 stainless steel, 6″ polystyrene and 3″ lead will reduce the combined leakage dose equivalent to 0.32 μSv (0.032 mrem) per laser pulse at 1 m from the chamber, which included the effect of all primary and secondary particles. Conclusion: We have designed an experimental setup to accommodate the laser focusing mirror, the target assemblies, the beam collimator and the particle selection system. Different shielding walls are designed to ensure the leakage dose equivalent to within 20 μSv (2 mrem)/week.

Original languageEnglish (US)
Pages (from-to)2117-2118
Number of pages2
JournalMedical Physics
Volume33
Issue number6
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Proton Therapy
Protons
Lasers
Polystyrenes
Stainless Steel
Electrons
Radiotherapy
Ions
Technology
Equipment and Supplies
Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Ma, C., Veltchev, I., Fourkal, E., Li, J., Fan, J., Lin, T., ... Stathakis, S. (2006). SU‐FF‐T‐309: Laser‐Accelerated Proton Therapy: Target Chamber Design and Shielding Requirements. Medical Physics, 33(6), 2117-2118. https://doi.org/10.1118/1.2241226

SU‐FF‐T‐309 : Laser‐Accelerated Proton Therapy: Target Chamber Design and Shielding Requirements. / Ma, C.; Veltchev, I.; Fourkal, E.; Li, J.; Fan, J.; Lin, T.; Luo, W.; Stathakis, Sotirios.

In: Medical Physics, Vol. 33, No. 6, 2006, p. 2117-2118.

Research output: Contribution to journalArticle

Ma, C, Veltchev, I, Fourkal, E, Li, J, Fan, J, Lin, T, Luo, W & Stathakis, S 2006, 'SU‐FF‐T‐309: Laser‐Accelerated Proton Therapy: Target Chamber Design and Shielding Requirements', Medical Physics, vol. 33, no. 6, pp. 2117-2118. https://doi.org/10.1118/1.2241226
Ma, C. ; Veltchev, I. ; Fourkal, E. ; Li, J. ; Fan, J. ; Lin, T. ; Luo, W. ; Stathakis, Sotirios. / SU‐FF‐T‐309 : Laser‐Accelerated Proton Therapy: Target Chamber Design and Shielding Requirements. In: Medical Physics. 2006 ; Vol. 33, No. 6. pp. 2117-2118.
@article{dec1dfc11bf24ee7a286fd38ffdf7e05,
title = "SU‐FF‐T‐309: Laser‐Accelerated Proton Therapy: Target Chamber Design and Shielding Requirements",
abstract = "Purpose: Recent advances in laser technology have facilitated proton (light ion) acceleration using laser‐induced plasmas. In this work, we investigate target chamber designs and their shielding requirements for a laser‐proton therapy system. Method and Materials: This new therapy system employs laser‐accelerated protons. If successfully developed, it may provide a compact and cost‐effective solution to energy‐ and intensity‐modulated proton therapy (EIMPT). Since laser‐accelerated protons have broad energy and angular distributions, which are not suitable for radiotherapy applications directly, we have designed a compact particle selection and beam collimating system for EIMPT beam delivery. The target chamber contains the laser focusing and target assembles and is connected to the proton beam collimation and particle selection device. Monte Carlo simulations using MCNPX and FLUKA have been performed to verify the shielding walls for the experimental setup, which consist of stainless steel, polystyrene and lead. Results: The primary particles resulting from the laser‐target interaction are protons and electrons. Our particle in cell simulation predicted energy spectra with 300 MeV maximum energy for protons and 20 MeV for electrons for a laser intensity of 1021 W/cm2. The maximum number was 1011 and 1012 per pulse for protons and electron, respectively. Our Monte Carlo simulations showed that a combination of 1/4″ 304 stainless steel, 6″ polystyrene and 3″ lead will reduce the combined leakage dose equivalent to 0.32 μSv (0.032 mrem) per laser pulse at 1 m from the chamber, which included the effect of all primary and secondary particles. Conclusion: We have designed an experimental setup to accommodate the laser focusing mirror, the target assemblies, the beam collimator and the particle selection system. Different shielding walls are designed to ensure the leakage dose equivalent to within 20 μSv (2 mrem)/week.",
author = "C. Ma and I. Veltchev and E. Fourkal and J. Li and J. Fan and T. Lin and W. Luo and Sotirios Stathakis",
year = "2006",
doi = "10.1118/1.2241226",
language = "English (US)",
volume = "33",
pages = "2117--2118",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐FF‐T‐309

T2 - Laser‐Accelerated Proton Therapy: Target Chamber Design and Shielding Requirements

AU - Ma, C.

AU - Veltchev, I.

AU - Fourkal, E.

AU - Li, J.

AU - Fan, J.

AU - Lin, T.

AU - Luo, W.

AU - Stathakis, Sotirios

PY - 2006

Y1 - 2006

N2 - Purpose: Recent advances in laser technology have facilitated proton (light ion) acceleration using laser‐induced plasmas. In this work, we investigate target chamber designs and their shielding requirements for a laser‐proton therapy system. Method and Materials: This new therapy system employs laser‐accelerated protons. If successfully developed, it may provide a compact and cost‐effective solution to energy‐ and intensity‐modulated proton therapy (EIMPT). Since laser‐accelerated protons have broad energy and angular distributions, which are not suitable for radiotherapy applications directly, we have designed a compact particle selection and beam collimating system for EIMPT beam delivery. The target chamber contains the laser focusing and target assembles and is connected to the proton beam collimation and particle selection device. Monte Carlo simulations using MCNPX and FLUKA have been performed to verify the shielding walls for the experimental setup, which consist of stainless steel, polystyrene and lead. Results: The primary particles resulting from the laser‐target interaction are protons and electrons. Our particle in cell simulation predicted energy spectra with 300 MeV maximum energy for protons and 20 MeV for electrons for a laser intensity of 1021 W/cm2. The maximum number was 1011 and 1012 per pulse for protons and electron, respectively. Our Monte Carlo simulations showed that a combination of 1/4″ 304 stainless steel, 6″ polystyrene and 3″ lead will reduce the combined leakage dose equivalent to 0.32 μSv (0.032 mrem) per laser pulse at 1 m from the chamber, which included the effect of all primary and secondary particles. Conclusion: We have designed an experimental setup to accommodate the laser focusing mirror, the target assemblies, the beam collimator and the particle selection system. Different shielding walls are designed to ensure the leakage dose equivalent to within 20 μSv (2 mrem)/week.

AB - Purpose: Recent advances in laser technology have facilitated proton (light ion) acceleration using laser‐induced plasmas. In this work, we investigate target chamber designs and their shielding requirements for a laser‐proton therapy system. Method and Materials: This new therapy system employs laser‐accelerated protons. If successfully developed, it may provide a compact and cost‐effective solution to energy‐ and intensity‐modulated proton therapy (EIMPT). Since laser‐accelerated protons have broad energy and angular distributions, which are not suitable for radiotherapy applications directly, we have designed a compact particle selection and beam collimating system for EIMPT beam delivery. The target chamber contains the laser focusing and target assembles and is connected to the proton beam collimation and particle selection device. Monte Carlo simulations using MCNPX and FLUKA have been performed to verify the shielding walls for the experimental setup, which consist of stainless steel, polystyrene and lead. Results: The primary particles resulting from the laser‐target interaction are protons and electrons. Our particle in cell simulation predicted energy spectra with 300 MeV maximum energy for protons and 20 MeV for electrons for a laser intensity of 1021 W/cm2. The maximum number was 1011 and 1012 per pulse for protons and electron, respectively. Our Monte Carlo simulations showed that a combination of 1/4″ 304 stainless steel, 6″ polystyrene and 3″ lead will reduce the combined leakage dose equivalent to 0.32 μSv (0.032 mrem) per laser pulse at 1 m from the chamber, which included the effect of all primary and secondary particles. Conclusion: We have designed an experimental setup to accommodate the laser focusing mirror, the target assemblies, the beam collimator and the particle selection system. Different shielding walls are designed to ensure the leakage dose equivalent to within 20 μSv (2 mrem)/week.

UR - http://www.scopus.com/inward/record.url?scp=84878886396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878886396&partnerID=8YFLogxK

U2 - 10.1118/1.2241226

DO - 10.1118/1.2241226

M3 - Article

AN - SCOPUS:84878886396

VL - 33

SP - 2117

EP - 2118

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -